The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia
- PMID: 20176725
- PMCID: PMC2851187
- DOI: 10.1210/en.2009-0788
The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia
Abstract
Physiological states of insulin resistance such as obesity and diabetes have been linked to abnormalities in female reproductive function. However, it is difficult to distinguish the direct effects of impaired insulin signaling from those of adiposity or hyperglycemia because these conditions often coexist in human syndromes and animal models of insulin resistance. In this study, we used lean, normoglycemic mouse lines with differing degrees of hyperinsulinemia and insulin receptor (Insr) expression to dissect the effects of altered insulin signaling on female reproduction. All three mouse lines [Ttr-Insr(-/-), Insr(+/-), and Insr(+/+) (wild type)] are able to maintain fertility. However, the insulin-resistant and hyperinsulinemic mice demonstrate altered duration of estrous cycles as well as aberrant distribution and morphology of ovarian follicles. These effects appear to be independent of hyperandrogenism in the mice. Pregnancy studies indicate decreased success in early progression of gestation. In successful pregnancies, decreased embryo weights and increased placental calcification also implicate altered insulin signaling in later gestational effects. Thus, abnormal insulin signaling, independent of adipose tissue mass, adipokine expression levels, and hyperglycemia, can affect parameters of the female hypothalamic-pituitary-gonadal axis and pregnancy outcomes.
Figures




References
-
- Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800 - PubMed
-
- Legro RS 2001 Polycystic ovary syndrome: the new millennium. Mol Cell Endocrinol 184:87–93 - PubMed
-
- Diamanti-Kandarakis E, Kandarakis HA 2003 Conservative management of gynecological diseases: insulin sensitizing agents in polycystic ovary syndrome. Ann NY Acad Sci 997:322–329 - PubMed
-
- Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM 2006 Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 91:4459–4466 - PubMed
-
- Kjaer K, Hagen C, Sandø SH, Eshøj O 1992 Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 75:524–529 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous